<DOC>
	<DOCNO>NCT01731210</DOCNO>
	<brief_summary>The LENEA study international , prospective , open label , non-randomized multicenter clinical research study design assess safety effectiveness NANO LV lead system .</brief_summary>
	<brief_title>Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation ( LENEA )</brief_title>
	<detailed_description />
	<criteria>Approved indication per ACC/AHA/HRS guideline implantation CRTD system treatment heart failure life threaten ventricular tachyarrhythmia ( ) Receiving new implant OR undergo upgrade exist ICD pacemaker implant prior implant LV lead OR undergo new LV implant attempt consecutive recent LV lead placement failure relate coronary sinus cannulation failure Patient receiving PARADYM RF CRT PARADYM RF CRT SONR device Ability provide inform consent study participation willing able comply prescribe followup test schedule evaluation Ventricular tachyarrhythmia transient reversible cause acute myocardial infarction , digitalis intoxication , drown , electrocution , electrolyte imbalance , hypoxia sepsis , uncorrected time enrolment ; Incessant Ventricular tachyarrhythmias ; Unstable angina , acute MI , CABG , PTCA within past 4 week ; Correctable valvular disease primary cause heart failure ; Post heart transplant ( patient wait heart transplant allow study ) ; Patient previously permanently implant LV lead ; Concurrent implant another pacemaker ICD ( previously implant pacemaker ICD device remove prior implant Paradym RF CRTD Paradym RF CRT SONR ) ; Already include another clinical study could confound result study ; Life expectancy less 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>